An interventional study of Aerobic exercise in Depression - Major Depressive Disorder, sponsored by Peking University. Recruiting at 1 site in China. Open to participants aged 18 Years to 45 Years. Per ClinicalTrials.gov, last updated 2025-07-02.
Sponsored by Peking University · Not applicable, Interventional, and Treatment
Help build ClinicalTrials.gg — short surveys, remote interviews or testing, in your language. Take part →
Among 21 studies in Depression by Peking University — 10 open to participants now, 13 under way, none of them phase 3. Depression · Peking University.
Among the 21 studies in Depression by Peking University, this one is the 20th largest by planned enrollment of the 20 interventional ones that give a count, is one of 5 that started in 2024, is one of 19 with no phase, reaches primary completion later than 5 of the 12 other live ones, and was the 8th registered.
8,608 studies on the registry are indexed under Depression; 1,736 are open to participants now.
Browse Depression studies →10 of the 21 studies in Depression by Peking University are open now, in 1 country. Recruiting first, the newest first:
Peking University · Sites in China
Ages 18–50
Peking University · Sites in China
Ages 18–65
Peking University · Sites in China
Ages 18+
Peking University · Sites in China
Ages 10–18 · Healthy volunteers
Peking University · Sites in China
Ages 14–60
By country, each count listing its studies:
Of the 1,098 Depression studies recruiting now, 475 (43%) set no upper age limit and 522 (48%) stop at 75 or younger; 205 take children under 18; 315 take healthy volunteers.
This study: 18 Years to 45 Years · all sexes · no healthy volunteers.
The full table on the hub →This tab as a report to print or save as PDF → With an account.
21 studies; the count open now beside each. This study's row is marked.
First in 2010; this study’s year is marked. 5 started in 2024.
By drug class, each counting the studies that test any of its medicines:
This study's planned enrollment of 80 is close to the median of 81 across 7,089 interventional studies indexed under Depression.
Median enrollment 200 across the 20 interventional studies, 7,000 across the 1 observational. Of the 4 that completed or were terminated, 0 (0%) have results posted.
This tab as a report to print or save as PDF → With an account.
Peking University is the lead sponsor of 420 studies on the registry; 124 are open to participants now.
4 of the studies in Depression by Peking University that are under way reach primary completion within a year, 0 of them phase 3. Phase 3 first, then by date:
| Study | Primary completion |
|---|---|
| NCT07692269Peking UniversityMindfulness Intervention for Emotional Distress: An EEG Study | 2026-12 |
| NCT07809737Peking UniversityThe Dynamic Mechanism of Mindfulness Intervention for Emotional Distress (MIED) Based on Ecological Moment Measurement | 2026-12-01 |
| NCT07480525Peking UniversityEfficacy and Mechanisms of Escitalopram in Drug-Naïve First-Episode Major Depressive Disorder | 2026-12-31 |
| NCT06831435Peking UniversityEffectiveness of Digital Cognitive Behavioral Therapy for the Treatment of Depression: a Real-world Study | 2026-12-31 |
Add all 4 to your calendar (.ics) → With an account.
Among the 21 studies in Depression by Peking University, from their registry updates:
Nothing recorded among them since 2026-09-25.
This tab as a report to print or save as PDF → With an account.
The goal of this project is to quantify the relative effectiveness of aerobic exercise monitored by smart wristbands in assisting the treatment of depression and improving cognitive function. It aims to explore the mechanisms through which aerobic exercise exerts its effects using imaging genetics and other methods, and to identify suitable populations for exercise, ultimately providing personalized clinical exercise prescriptions. This study will intervene from a behavioral perspective and also seeks to motivate participants to change and improve their physical activity habits.
Go through the criteria one by one — yes, no or not sure — and take the list to your doctor or the study team. Kept in this browser only.
Exclusion Criteria:
Underlined terms in the criteria open these too. Explained by clinicaltrials.gg, not part of the registry record. The study team decides who can take part.
The American Psychiatric Association’s manual of mental health diagnoses. DSM-5 (2013, revised as DSM-5-TR in 2022) replaced DSM-IV, and some studies still name the older edition. “Meets DSM criteria for …” means diagnosed by that edition’s diagnostic criteria, usually by a clinician in an interview.
Before you join, the study team explains what taking part involves — its purpose, what happens, the risks and possible benefits — and answers your questions, so you can decide freely. Consent is usually recorded on a form (the informed consent form, ICF) signed by you or, where the law allows, by someone legally authorized to decide for you.
You can keep asking questions during the study, you are told of new information that matters, and you can choose to leave at any time.
A reason a treatment, test or procedure should not be given to a particular person, such as an allergy, another illness or a medicine they take.
DSM diagnostic criteria
The American Psychiatric Association’s manual of mental health diagnoses. DSM-5 (2013, revised as DSM-5-TR in 2022) replaced DSM-IV, and some studies still name the older edition. “Meets DSM criteria for …” means diagnosed by that edition’s diagnostic criteria, usually by a clinician in an interview.
Explained by clinicaltrials.gg, not part of the registry record. The study team decides who can take part.
Informed consent
Before you join, the study team explains what taking part involves — its purpose, what happens, the risks and possible benefits — and answers your questions, so you can decide freely. Consent is usually recorded on a form (the informed consent form, ICF) signed by you or, where the law allows, by someone legally authorized to decide for you.
You can keep asking questions during the study, you are told of new information that matters, and you can choose to leave at any time.
Explained by clinicaltrials.gg, not part of the registry record. The study team decides who can take part.
Contraindication
A reason a treatment, test or procedure should not be given to a particular person, such as an allergy, another illness or a medicine they take.
Explained by clinicaltrials.gg, not part of the registry record. The study team decides who can take part.
Aerobic exercise intervention combined with conventional drug treatment
Behavioral: Aerobic exercise
Antidepressants were routinely used and aerobic exercise interventions were performed at the end of the 8-week follow-up
Moderate-intensity aerobic exercise for 30-50 minutes three times a week was added to usual medical therapy
Change from baseline in Hamilton Depression Rating Scale (HAMD)
The outcome is assessed by HAMD-17 Scale.
Time frame: Week 4 and 8 of treatment duration
Change from baseline in THINC-it score
Time frame: Week 4 and 8 of treatment duration
Change from baseline in Montgomery-Åsberg Depression Rating Scale (MADRS)
Time frame: Week 4 and 8 of treatment duration
Response to treatment
The reduction rate of HAMD-17 or MADRS score was ≥50%
Time frame: Week 4 and 8 of treatment duration
Clinical Global Impression-Severity of Illness (CGI-S)
Time frame: Week 4 and 8 of treatment duration
Change from baseline in Hamilton Anxiety Rating Scale (HAMA)
Time frame: Week 4 and 8 of treatment duration
Change from baseline in Ruminative Responses Scale (RRS)
Time frame: Week 4 and 8 of treatment duration
Change from baseline in Pittsburgh Sleep Quality Index (PSQI)
Time frame: Week 4 and 8 of treatment duration
Change from baseline in Connor-Davidson Resilience Scale (CD-RISC)
Time frame: Week 4 and 8 of treatment duration
Rating Scale for Side Effects (SERS) -Antidepressant
Rating Scale for Side Effects (SERS) -Antidepressant
Time frame: Week 4 and 8 of treatment duration
Mood Disorder Questionnaire (MDQ)
Time frame: Week 4 and 8 of treatment duration
International Physical Activity Questionnaire (IPAQ)
Time frame: Week 4 and 8 of treatment duration
Biomarkers level
CRP, IL-1β, TNF-α, IL-6, IL-8, IL-10 and other immune factors, irisin, neurotrophic factor BDNF, vascular endothelial growth factor VEGF, and insulin growth factor IGF-1, NLRP3, CXCL8, CXCL3, CCL5, etc
Time frame: Week 0 and 8 of treatment duration
Body weight in kilograms
Time frame: Week 4 and 8 of treatment duration
Body fat rate
Time frame: Week 4 and 8 of treatment duration
Brain imaging features
Acquisition was performed by magnetic resonance imaging
Time frame: Week 0 and 8 of treatment duration
Plan to share: No
No publications or documents are linked to this record.
Started Sep 2024 (actual). Primary completion is estimated for Oct 2025, 13 months after the start.
Of 3,486 non-industry interventional studies with no phase under Depression, half reached primary completion within 21 months of starting (the median), counting those still running; a quarter within 10 and three quarters within 41. This study's planned 13 months is below that.
Counting every sponsor, half of 3,584 studies reached it within 21 months; a quarter within 9 and three quarters within 41.
How these figures are worked out, and which studies are left out of them.
Eligibility is decided by the study team. Share this record with your doctor or contact the team directly.
Contact study teamGet an email when the registry record changes — status, dates, results — or when someone posts here.
Sign in to followQuestions and observations about this study, from anyone following it. Not medical advice, and not a channel to the study team — their contact details are on the registry record.
Sign in to join the discussion. Reading takes no account; posting does. You choose a display name, and a pseudonym is the default.
Nothing here yet. If you are running this trial, taking part in it, or weighing whether to, this is the place to say so.